Search Results
Sep 09, 2026, 08:55 ET CUBEX launches Essentials
after-the-fact reconciliation.Documentation built as the work happens. Digital drug logs are generated automatically and formatted for DEA review, so DEA recordkeeping is not a separate step at the end of a shift.Inventory that counts itself. Because dispensing and counting are
More news about: CUBEX®
Sep 02, 2026, 11:17 ET Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders
has removed the 280E tax treatment and ceased future accruals of the liability. The rescheduling of adult use cannabis is currently in process by the DEA and a similar outcome is expected.Curaleaf's UTP balance as a percentage of TEV (13%) is one of the lowest relative to the U.S. cannabis peer
More news about: Curaleaf Holdings, Inc.
Aug 31, 2026, 09:08 ET The National Police Association Supports NYPD Detectives Fighting to Protect Earned Benefits
officers, retirees, their families, and Americans who stand with the police to sign the petition calling upon the NYPD Detectives' Endowment Association (DEA) to reject reductions in dental benefits and restore the coverage detectives earned through their service. This fight is about keeping faith with
More news about: National Police Association
Aug 25, 2026, 11:06 ET Licensed Pharmacists Mark Poling, PharmD, and John Mezger, PharmD, Explain Prescription Transfer in HelloNation
controlled-substance medications. Federal regulations permit certain electronic Schedule II through Schedule V prescriptions to be transferred once between DEA-registered retail pharmacies when requested by the patient and allowed under state law. Additional federal rules apply to refill transfers for Schedule
More news about: HelloNation
Aug 25, 2026, 09:00 ET ASRC Federal Selected to Modernize and Operate Enterprise IT for U.S. Drug Enforcement Administration
Federal announced today that its subsidiary, ASRC Federal Technology Solutions LLC (AFTS), has been awarded the DEA Delta Code contract by the U.S. Department of Justice Drug Enforcement Administration (DEA). Through this competitively recompeted program, the company will provide planning, implementation and maintenance
More news about: ASRC Federal
Aug 18, 2026, 08:00 ET Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE
marijuana rescheduling to Schedule III in April 2026, all 207 Trulieve medical dispensaries were registered with the U.S. Drug Enforcement Administration (DEA), with inspections completed in Florida, Pennsylvania, and West Virginia.Georgia: Medical marijuana program expansion
More news about: Trulieve Cannabis Corp.
Aug 12, 2026, 16:00 ET AWH Reports Second Quarter 2026 Financial Results
common stock in support of a planned uplisting to a major U.S. exchange.Submitted applications with the U.S. Drug Enforcement Administration ("DEA") to register certain state-licensed medical cannabis operations under the expedited registration pathway established in connection with the rescheduling
More news about: Ascend Wellness Holdings, Inc.
Aug 11, 2026, 13:38 ET Don Worley Joins Pete Davidson Crime Thriller Tommy Karate as "Sensei Matt," Also Serving as Executive Producer
mob killers. Davidson stars as Pitera in what he has described as his "dream role," while acclaimed actor Paul Walter Hauser portrays legendary DEA Agent Jim Hunt, the lawman who ultimately brought Pitera to justice. The ensemble also includes Camila Mendes and Simon Rex. The project
More news about: Kimball Entertainment
Aug 11, 2026, 13:00 ET Health Law Alliance Expands Healthcare Audit Defense Teams with Addition of Former New Jersey Deputy Attorney General and UPIC Audit Investigator
and state enforcement targeting healthcare providers, including hospice and home health agencies, wound care clinicians, DME suppliers, laboratories, DEA registrants, and Medicaid ancillary services.About Health Law AllianceHealth Law Alliance is a national healthcare defense firm
More news about: Health Law Alliance
Aug 11, 2026, 11:00 ET BRC Therapeutics Founder and CEO George Hodgin to Speak at Nucleate Global Summit 2026
Arthralgia (AIIA), Restless Legs Syndrome (RLS), and an additional confidential neurological condition. The company has an extensive patent portfolio, a DEA Schedule I Bulk Manufacturing Registration, and multiple active INDs for programs in the clinic."My time in special operations taught me that
More news about: BRC Therapeutics
Aug 05, 2026, 16:01 ET Curaleaf Reports Second Quarter 2026 Results: Continued Growth, Margin Strength, and Profitability
increasing ownership of Curaleaf International to 100%Applied to register all our medical cultivation, processing, and dispensing locations with the DEAAppointed Torsten Greif, co-founder and managing director of Four 20 Pharma, and Faith Charles, partner at Thompson Hine LLP, to Curaleaf's Board
More news about: Curaleaf Holdings, Inc.
Aug 05, 2026, 08:33 ET Aveva Drug Delivery Systems Prevails on Appeal, Federal Circuit Affirms Non-Infringement of ZTlido® Patents - Prepares for an Imminent Launch of its Generic Product with 180 Day Exclusivity
Delivery Systems (TDS), and Oral Dissolvable Films (ODF). Aveva is licensed to manufacture, package, and market OTC & Rx TDS and ODF products and is DEA-approved for Schedule II & III controlled substance storage and handling. Aveva's licensed facilities, located in Miramar, FL, span four sites totaling
More news about: DifGen Pharmaceuticals LLC
Aug 04, 2026, 16:05 ET Qualys Announces Second Quarter 2026 Financial Results
HighlightsQualys' TotalCloud solution achieved FedRAMP High Authorization, sponsored by the U.S. Drug Enforcement Administration (DEA). This extends the Qualys Government Platform's authorization to include Cloud-Native Application Protection Platform (CNAPP) capabilities and makes
More news about: Qualys, Inc.
Jul 30, 2026, 09:26 ET Hamilton Morris Documentary Takes Viewers Inside the CBD American Shaman Lab Where 7-OH Is Made
weight for botanical material, and 0.050 percent by weight or volume, or more than 1.00 milligram per article, for synthetic and processed forms. The DEA notice states it "was adapted from the definition used by the Department of Health and Human Services," and includes no dose-response analysis.An
More news about: CBD American Shaman
Jul 16, 2026, 06:45 ET Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
fourth anniversary of closing; (b) $0.50 per share upon U.S. regulatory approval and DEA rescheduling of BPL-003 prior to the fifth anniversary of closing; and (c) $1.00 per share upon U.S. regulatory approval and DEA rescheduling of VLS-01 prior to the seventh anniversary of closing. The upfront cash
More news about: Eli Lilly and Company
Jul 01, 2026, 10:00 ET BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES
rooms' are ideal for fast-tracking Research & Development.Founded in 1987, and based in Salem, NH - BA Sciences is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 certified analytical laboratory, and is a trusted provider of high-quality analytical testing services to life science
More news about: BioSapien Inc
Jul 01, 2026, 08:10 ET Trulieve Commemorates Georgia Medical Cannabis Launch with First Sale
220."Following federal rescheduling of medical marijuana to Schedule III in April, independent pharmacies in Georgia with state licensure and DEA registration may sell medical cannabis products to qualified patients. Trulieve has begun providing products to over a dozen pharmacies and expects to
More news about: Trulieve Cannabis Corp.
Jun 30, 2026, 08:00 ET AWH Files DEA Registration Applications for State-Licensed Medical Cannabis Operations
cannabis operator and consumer packaged goods company, today announced that it has filed applications with the U.S. Drug Enforcement Administration ("DEA") to register certain state-licensed medical cannabis operations under the expedited registration pathway established in connection with the rescheduling
More news about: Ascend Wellness Holdings, Inc.
Jun 17, 2026, 11:00 ET Curaleaf and Trulieve Lead the 5W AI Intelligence Cannabis Citation Ranking
legalization began. President Trump signed an executive order on December 18, 2025 directing the rescheduling of cannabis to Schedule III. The DOJ and DEA finalized the order on April 23, 2026, placing FDA-approved marijuana products and state-licensed medical marijuana into Schedule III. A broader rescheduling
More news about: 5W Public Relations
Jun 17, 2026, 07:01 ET ARMR Sciences Achieves Major Milestone Toward Overdose Protection, Produces First-Ever Anti-Fentanyl Immune Response in Humans
https://www.dea.gov/press-releases/2024/01/31/year-review-dea-rocky-mountain-field-division-sees-record-year-fentanyl
More news about: ARMR Sciences Inc.
Jun 16, 2026, 16:05 ET Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia
noradrenergic and dopaminergic neurons, as well as thalamocortical neurons.22 The U.S. Drug Enforcement Agency (DEA) has designated Xywav as a Schedule III medicine. The DEA defines Schedule III drugs, substances, or chemicals as drugs with a moderate to low potential for physical and psychological
More news about: Jazz Pharmaceuticals plc
Jun 15, 2026, 16:00 ET High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM
Schedule III of the Controlled Substances Act, the most significant shift in U.S. federal cannabis regulation in decades. Building on that order, the DEA has scheduled a new administrative hearing to begin on June 29, 2026 to consider whether all cannabis should be moved from Schedule I to Schedule III.
More news about: High Tide Inc.
Jun 13, 2026, 12:35 ET Gala Night of the 28th Shanghai International Film Festival Held in Shanghai
Chiu-wai and includes Chinese director Guan Hu, actress Xin Zhilei, Tunisian producer Dora Bouchoucha, Kyrgyz director Aktan Arym Kubat, Georgian filmmaker Déa Kulumbegashvili and Mexican director Fernanda Valadez."It is a great honor to serve as jury president of the 28th Shanghai International Film
More news about: SIFF
Jun 05, 2026, 07:00 ET Trulieve Announces Uplist to NYSE
2025. The final order issued in April rescheduled state licensed medical marijuana products and created a pathway for Drug Enforcement Administration ("DEA") registration for state licensed medical marijuana businesses under the treaty authority pursuant to the United Nations Single Convention on Narcotic
More news about: Trulieve Cannabis Corp.
Jun 04, 2026, 12:24 ET Victoria's Voice Foundation Marks National Naloxone Awareness Day on June 6
leader on overdose response and prevention, and a Victoria's Voice board member – White House National Drug Control Policy Director Sara Carter, and DEA Assistant Administrator Cheri Oz. "America's drug epidemic spares no party, family, or state. We all know someone who has been impacted by the
More news about: Victoria’s Voice Foundation